Sloan Leslie 4
4 · Aeglea BioTherapeutics, Inc. · Filed Mar 8, 2019
Insider Transaction Report
Form 4
Sloan Leslie
Chief Operating Officer
Transactions
- Award
Employee Stock Option (right to buy)
2019-03-06+36,000→ 36,000 totalExercise: $8.06Exp: 2029-03-05→ Common Stock (36,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 48 equal monthly installments beginning on April 6, 2019, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.